Data as of Aug 29
| +0.26 / +3.08%|
The 3 analysts offering 12-month price forecasts for Pernix Therapeutics Holdings Inc have a median target of 9.00, with a high estimate of 10.00 and a low estimate of 7.00. The median estimate represents a +3.57% increase from the last price of 8.69.
The current consensus among 3 polled investment analysts is to Buy stock in Pernix Therapeutics Holdings Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.